Turn Therapeutics (TTRX) Change in Cash (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Change in Cash of $6.1 million in Q1 2026, up 211.75% quarter-over-quarter from $2.0 million in Q4 2025, and up 777.32% on a YoY basis from $700034.0 in Q1 2025.
Turn Therapeutics (TTRX) Change in Cash (2024 - 2026) Analysis & Trends
Turn Therapeutics' Change in Cash history runs 3 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Change in Cash rose 777.32% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $8.9 million (changed N/A YoY), while the FY2025 annual figure was $4.2 million, up 1463.03% from the prior year.
- Change in Cash was $6.1 million for Q1 2026 at Turn Therapeutics, up from $2.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $6.1 million in Q1 2026 to a low of $83819.0 in Q4 2024.
- Historically, Change in Cash has averaged $2.2 million across 3 years, with a median of $1.3 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Change in Cash soared 2250.29% in 2025, then soared 777.32% in 2026.
- A 3-year view of Change in Cash shows it stood at $83819.0 in 2024, then jumped by 2250.29% to $2.0 million in 2025, then soared by 211.75% to $6.1 million in 2026.
- The last three Change in Cash figures came in at $6.1 million (Q1 2026), $2.0 million (Q4 2025), and $700034.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | 6.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Mar 31, 2025 | 700,034.00 |
| Dec 31, 2024 | 83,819.00 |